Tops & Flops Stocks
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Sangamo Therapeutics Inc. | -6.010% | -13.928% | -44.508% | -75.121% | -47.992% | -96.969% | -97.081% |
Novavax Inc. | -5.970% | -7.143% | -43.038% | 61.495% | 145.733% | -94.088% | 142.609% |
Hexo Corp. | -5.340% | - | - | - | - | - | - |
Erytech Pharma S.A. | -5.170% | - | - | - | - | - | - |
Synthetic Biologics Inc. | -5.070% | -1.580% | -8.017% | -74.503% | -45.500% | -95.514% | -95.880% |
Actinium Pharmaceuticals Inc. | -5.070% | -5.839% | -13.655% | -5.147% | 42.699% | -1.527% | - |
Cardio3 Biosciences S.A. | -5.040% | -1.875% | -12.939% | -50.732% | -31.739% | -94.332% | -97.927% |
Forte Biosciences Inc. | -5.020% | -5.417% | -14.340% | -50.110% | -29.612% | -98.424% | - |
Paion AG | -4.910% | - | - | - | - | - | - |
Vanda Pharmaceuticals | -4.840% | -9.057% | 2.119% | -19.667% | 24.227% | -73.516% | - |
Ocuphire Pharma Inc. | -4.760% | -1.264% | -12.125% | -64.041% | -49.696% | -66.039% | - |
Oncolytics Biotech | -4.730% | - | - | - | - | - | - |
Cumberland Pharmaceuticals | -4.690% | - | - | - | - | - | - |
Cellectis Nom. | -4.560% | 9.423% | -24.625% | -0.642% | -35.887% | -85.530% | - |
Pharmaxis Ltd. | -4.550% | - | - | - | - | - | - |
Fennec Pharmaceuticals Inc. | -4.500% | -7.018% | -13.115% | -32.484% | -48.544% | -7.826% | 50.248% |
Oramed Pharmaceuticals | -4.450% | -3.549% | 13.402% | -28.261% | 9.168% | -77.788% | -19.456% |
Trinity Biotech ADR | -4.440% | - | - | - | - | - | - |
Immunic Inc. | -4.340% | -4.667% | -12.576% | -61.939% | -30.000% | -91.063% | - |
Brainstorm Cell | -4.330% | -4.622% | -21.046% | -83.449% | 36.947% | -90.016% | -91.398% |
Insmed Inc. | -4.200% | -8.800% | 8.571% | 198.429% | 99.301% | 137.500% | 156.583% |
Spectrum Pharmaceuticals | -4.190% | - | - | - | - | - | - |
Syndax Pharmaceuticals Inc | -4.150% | -3.125% | 3.911% | -4.615% | -0.535% | 19.231% | - |
Elite Pharmaceut. | -4.110% | - | - | - | - | - | - |
Epigenomics AG NA | -4.040% | - | - | - | - | - | - |